Back to ASND

SILVERARC CAPITAL MANAGEMENT, LLC → ASND

SILVERARC CAPITAL MANAGEMENT, LLC ASND Position History

Ascendis Pharma A/S • Healthcare

Quarters held
4
Latest value
$34.7M
Q3 2026
Peak value
$55M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$10.5M
Q1 2026$28.5M
Q2 2026$55M
Q3 2026$34.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$34.7M152.2K——
Q2 2026$55M206.2K——
Q1 2026$28.5M124.7K——
Q4 2025$10.5M49.2K——

Other funds holding ASND

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
DNTH

DIANTHUS THERAPEUTICS INC

$54.9M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M
COGT

COGENT BIOSCIENCES INC

$50.4M